The stringent demands for validation and testing in life sciences are getting an automation overhaul. UiPath, a leader in agentic automation, has joined the Veeva AI Partner Program to integrate its testing and automation capabilities with Veeva's Validation Management system. The partnership aims to deliver agentic, end-to-end workflows that transform computer software assurance (CSA) testing, creating a fully digital, audit-ready, and paperless validation process for quality management in highly regulated environments.
UiPath has joined the Veeva AI Partner Program to deliver agentic testing and validation solutions.
The partnership integrates UiPath Test Manager with Veeva Validation Management for a synchronized, digital workflow.
It enables real-time traceability between requirements, test cases, and results, ensuring compliance and audit readiness.
UiPath's UI automation and a pre-built Veeva API connector allow for resilient, end-to-end testing across cloud and on-premises systems.
The goal is to help life sciences companies reduce validation cycle times, errors, and costs while improving accuracy.
Partners CGI and Deloitte endorse the collaboration for driving operational efficiency and innovation in life sciences.
At the core of the partnership is the synchronization of Veeva Validation Management, a system of record for compliance, with UiPath Test Manager, an orchestration and execution engine. This integration creates a closed-loop system where test requirements, execution scripts, and pass/fail results are automatically synchronized between platforms. This eliminates manual handoffs and data reconciliation, ensuring continuous traceability—a critical requirement for regulatory inspections.
UiPath brings its "agentic automation" capabilities to the solution, meaning AI-driven bots can autonomously execute complex test scripts across diverse application environments, including Veeva's cloud-based platforms and on-premises systems. The inclusion of a pre-built Veeva API connector further allows for secure, API-driven workflow automation. This combination of UI and API automation aims to create resilient, self-healing testing processes that reduce manual effort and increase test coverage.
The life sciences industry faces immense pressure to accelerate innovation while maintaining flawless compliance. Joe Miles, Life Sciences Industry Lead at UiPath, highlighted the partnership's value: “The combination of UiPath agentic testing capabilities and Veeva Validation Management enables life sciences companies to dramatically reduce costs, errors, and cycle times while improving accuracy and audit readiness.” By automating the validation evidence creation process "by design," the solution seeks to turn a traditional bottleneck into a competitive advantage.
The collaboration is bolstered by endorsements from major system integrators. Douglas Vargo of CGI called it a "catalyst for innovation," while Saurayan Chaki of Deloitte noted it enables "autonomous, self-healing validation processes that reduce cycle time and rework." This third-party validation underscores the practical value for enterprises navigating digital transformation in regulated sectors.
This partnership represents a significant step in the convergence of specialized industry software (Veeva) and horizontal automation platforms (UiPath). It delivers a targeted solution that promises to enhance quality, speed, and confidence in software validation for life sciences—a sector where the stakes for accuracy and compliance are exceptionally high.
About UiPath
UiPath is a global leader in agentic automation, empowering enterprises to harness the full potential of AI agents to autonomously execute and optimize complex business processes. The UiPath Platform™ uniquely combines controlled agency, developer flexibility, and seamless integration to help organizations scale agentic automation safely and confidently. Committed to security, governance, and interoperability, UiPath supports enterprises as they transition into a future where automation delivers on the full potential of AI to transform industries.